Variant report
Variant | esv3426873 |
---|---|
Chromosome Location | chr1:191738329-191740477 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375545108 | chr1:191738347-191738348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2785765 | chr1:191738357-191738358 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs569612833 | chr1:191738362-191738363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183816729 | chr1:191738408-191738409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555358711 | chr1:191738459-191738460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7417331 | chr1:191738494-191738495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12142870 | chr1:191738512-191738513 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs75570510 | chr1:191738599-191738600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12028157 | chr1:191738604-191738605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577955148 | chr1:191738610-191738611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115205985 | chr1:191738631-191738632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs143818945 | chr1:191738633-191738634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531846089 | chr1:191738740-191738741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375752018 | chr1:191738819-191738820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs151264693 | chr1:191738820-191738821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562117098 | chr1:191738829-191738830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187310360 | chr1:191738843-191738844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12744554 | chr1:191738881-191738882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546793440 | chr1:191738912-191738913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547723818 | chr1:191738948-191738949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570707181 | chr1:191738956-191738957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs5779596 | chr1:191738977-191738978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75516487 | chr1:191738978-191738979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397711650 | chr1:191738985-191738986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377385754 | chr1:191738986-191738987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140488813 | chr1:191739000-191739001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549450767 | chr1:191739030-191739031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs833978 | chr1:191739082-191739083 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs12093952 | chr1:191739121-191739122 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs550510001 | chr1:191739128-191739129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558976032 | chr1:191739213-191739214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192615131 | chr1:191739220-191739221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565682840 | chr1:191739265-191739266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138145262 | chr1:191739469-191739470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535252222 | chr1:191739554-191739555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142369378 | chr1:191739627-191739628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577894431 | chr1:191739647-191739648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146998125 | chr1:191739677-191739678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557137855 | chr1:191739760-191739761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184778838 | chr1:191739762-191739763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189195915 | chr1:191739805-191739806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192736740 | chr1:191739837-191739838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572153052 | chr1:191739863-191739864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541304894 | chr1:191739917-191739918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564476918 | chr1:191739973-191739974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184127096 | chr1:191740017-191740018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550079230 | chr1:191740028-191740029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190039322 | chr1:191740049-191740050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563912514 | chr1:191740058-191740059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528943900 | chr1:191740076-191740077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 17086460 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:191735200-191740000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:191739800-191741800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr1:191740000-191740600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr1:191740000-191741400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr1:191740000-191741600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr1:191740200-191740400 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
7 | chr1:191740200-191741200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr1:191740200-191741200 | Enhancers | Fetal Heart | heart |
9 | chr1:191740200-191741400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr1:191740200-191741600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr1:191740200-191741600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr1:191740400-191740600 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
13 | chr1:191740400-191741200 | Enhancers | H1 Cell Line | embryonic stem cell |
14 | chr1:191740400-191741200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr1:191740400-191741600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |